Power your decentralized trial with an agile randomization and trial supply management solution that supports supply flexibility and optimization as well as adaptable direct to patient options.
- Session 1: 2pm CET|1pm GMT|8am EST
- Session 2: 11am EST|8am PST|4pm GMT|5pm CET
Cost reductions achieved through automated supply optimization
Determining IRT inputs and outputs for automating forecasting and resupply- Applying experience and a retrospective analysis
- Should forecasting tools auto-update IRT settings?
- What human decisions should there be?
- Cost reductions achieved through automated supply optimization
Learn to:
- Identify study designs where cost and waste can be reduced through automation
- Apply case study success to your trial
- Discover new ways to optimize IP and drug supply operations
Speaker
![]() |
Stefan Dürr Senior Director, Client Delivery at Cenduit IRT, an IQVIA business Head of Drug Supply Center of Excellence |
Related solutions
Fast, flexible and proven, IQVIA’s industry-leading electronic clinical outcome assessment (eCOA) platform ramps up efficiencies, delivers real-time data, and sharpens insights through best-in-class technology and a better patient experience.
Technology informed by unparalleled Decentralized Trials (DCT) operational experience and delivered at global scale.
Ease the burden on your sites and make it easier and more appealing for patients to enroll and remain engaged.
Combine data science, technology, and analytics driven by artificial intelligence to support new efficiencies and business insights -- without additional capital investment.

